Zhou C - Search Results

1

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer.

Qu Y, Zhou C, Zhang J, Cai Q, Li J, Du T, Zhu Z, Cui X, Liu B. Qu Y, et al. Among authors: zhou c. Int J Oncol. 2014 May;44(5):1512-20. doi: 10.3892/ijo.2014.2328. Epub 2014 Mar 6. Int J Oncol. 2014. PMID: 24604109 Free PMC article.

2

mTOR activation in well differentiated pancreatic neuroendocrine tumors: a retrospective study on 34 cases.

Zhou CF, Ji J, Yuan F, Shi M, Zhang J, Liu BY, Zhu ZG. Zhou CF, et al. Hepatogastroenterology. 2011 Nov-Dec;58(112):2140-3. doi: 10.5754/hge11212. Hepatogastroenterology. 2011. PMID: 22024086

3

Cetuximab combined with FOLFOX4 as the first-line treatment for advanced gastric cancer: report of 25 cases from a single institution.

Shi M, Ji J, Wu J, Ma T, Liu Y, Zhou CF, Su Y, Ye ZB, Zhang J, Zhu ZG. Shi M, et al. Hepatogastroenterology. 2012 Jun;59(116):1054-8. doi: 10.5754/hge11874. Hepatogastroenterology. 2012. PMID: 22281975

4

[Impacts of Bevacizumab on vascular endothelial growth factor and Sp1 expression in gastric cancer xenografts].

Zhou CF, Ji J, Yuan F, Yu YY, Liu BY, Zhang J, Zhu ZG. Zhou CF, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Feb;15(2):180-4. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 22368029 Chinese.

5

Pancreatic neuroendocrine tumors: a comprehensive review.

Zhou C, Zhang J, Zheng Y, Zhu Z. Zhou C, et al. Int J Cancer. 2012 Sep 1;131(5):1013-22. doi: 10.1002/ijc.27543. Epub 2012 Apr 16. Int J Cancer. 2012. PMID: 22437917 Review.

6

UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer.

Zhou CF, Ma T, Su Y, Ye ZB, Ji J, Yu YY, Zhang J, Liu BY, Zhu ZG. Zhou CF, et al. Anticancer Agents Med Chem. 2013 Feb;13(2):235-41. doi: 10.2174/1871520611313020008. Anticancer Agents Med Chem. 2013. PMID: 22934695

7

[Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1].

Zhou CF, Ji J, Yuan F, Yu YY, Liu BY, Zhang J, Zhu ZG. Zhou CF, et al. Zhonghua Zhong Liu Za Zhi. 2012 Aug;34(8):592-5. doi: 10.3760/cma.j.issn.0253-3766.2012.08.007. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23158992 Chinese.

8

Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.

Shi M, Lou B, Ji J, Shi H, Zhou C, Yu Y, Liu B, Zhu Z, Zhang J. Shi M, et al. Among authors: zhou c. Cancer Chemother Pharmacol. 2013 Jul;72(1):35-44. doi: 10.1007/s00280-013-2166-1. Epub 2013 May 28. Cancer Chemother Pharmacol. 2013. PMID: 23712327

9

MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.

Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y, Liu B, Zhu Z, Zhang J. Zhou C, et al. Mol Cancer. 2013 Sep 8;12(1):102. doi: 10.1186/1476-4598-12-102. Mol Cancer. 2013. PMID: 24010737 Free PMC article.

10

Suberoylanilide hydroxamic acid enhances the antitumor activity of oxaliplatin by reversing the oxaliplatin‑induced Src activation in gastric cancer cells.

Zhou C, Ji J, Shi M, Yang L, Yu Y, Liu B, Zhu Z, Zhang J. Zhou C, et al. Mol Med Rep. 2014 Nov;10(5):2729-35. doi: 10.3892/mmr.2014.2548. Epub 2014 Sep 9. Mol Med Rep. 2014. PMID: 25199623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,062 results

Search Page

Filters